Evidence map›Paper›PMID 41507439›Full record

ArticleNPJ digital medicine2026

Leveraging large scale deep learning models for diagnosis and visual outcome prediction in retinitis pigmentosa.

Tatsuya Nagai, Koya Homma, Yuto Kawamata, Masahito Yoshihara, Eiryo Kawakami, Takayuki Baba

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tatsuya Nagai *Department of Ophthalmology and Visual Science, Graduate School of Medicine, Chiba University, Chiba, Japan.
Koya Homma *Department of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yuto KawamataDepartment of Ophthalmology and Visual Science, Graduate School of Medicine, Chiba University, Chiba, Japan.
Masahito YoshiharaDepartment of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Eiryo KawakamiDepartment of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan. eiryo.kawakami@chiba-u.jp.
Takayuki BabaDepartment of Ophthalmology and Visual Science, Graduate School of Medicine, Chiba University, Chiba, Japan. t.baba.oph@faculty.chiba-u.jp.

Funding

cience and Technology Agency (JST) Moonshot R&D grant JPMJMS2025JSPS Core-to-Core Program JPJSCCA20200006
6 · The paper itself

Abstract

Retinitis pigmentosa (RP) is an inherited progressive retinal degeneration that shows symptoms of night blindness, visual field loss, declining of vision and eventually, blindness. Currently, gene therapy and retinal prosthesis are available, but the indication for these treatments is limited. In this study, we report on the development of a diagnostic and prognostic model for RP based on large-scale deep learning (DL) models pre-trained with fundus images. The EfficientNetB4 model performed best in diagnosing RP with an AUC of 0.94. The diagnosis of RP with this model is superior in cases with good vision. For visual prognosis, we applied machine learning survival analysis to DL-derived image features and clinical metadata, using a strict patient-level split to avoid data leakage. The hybrid model combining imaging and clinical data outperformed models based on either modality alone, especially in female patients. Time-dependent AUC analysis showed that prognostic performance was highest between 500 and 1400 days after examination. SHAP-based interpretability analysis revealed that the features contributing to RP diagnosis and those associated with prognosis were distinct. While our findings demonstrate the added value of fundus images in visual outcome prediction, further validation using external and multi-center datasets is necessary for clinical translation.

Identifiers

PMID41507439
PMCPMC12887015

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.